Literature DB >> 11447198

Phagocytosis of wild-type Legionella pneumophila occurs through a wortmannin-insensitive pathway.

N Khelef1, H A Shuman, F R Maxfield.   

Abstract

Wild-type Legionella pneumophila grows in human macrophages within a replicative phagosome, avoiding lysosomal fusion, while nonreplicative mutants are killed in lysosomes. Wortmannin, a phosphatidylinositol 3-kinase (PI3K) inhibitor, blocks phagocytosis of an avirulent mutant, but not of wild-type L. pneumophila, without affecting membrane ruffling and actin polymerization. These results show that wild-type and mutant Legionella strains use different entry pathways. They suggest that PI3Ks are involved in phagocytosis of an avirulent L. pneumophila mutant and regulate the ability of microorganisms to generate a replicative phagosome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447198      PMCID: PMC98612          DOI: 10.1128/IAI.69.8.5157-5161.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Legionella pneumophila DotA protein is required for early phagosome trafficking decisions that occur within minutes of bacterial uptake.

Authors:  C R Roy; K H Berger; R R Isberg
Journal:  Mol Microbiol       Date:  1998-05       Impact factor: 3.501

2.  Signal transduction during Legionella pneumophila entry into human monocytes.

Authors:  P Y Coxon; J T Summersgill; J A Ramirez; R D Miller
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Direct effects of Pasteurella haemolytica lipopolysaccharide on bovine pulmonary endothelial cells in vitro.

Authors:  D B Paulsen; D A Mosier; K D Clinkenbeard; A W Confer
Journal:  Am J Vet Res       Date:  1989-09       Impact factor: 1.156

4.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

5.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil.

Authors:  M A Horwitz
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

7.  Legionella pneumophila inhibits acidification of its phagosome in human monocytes.

Authors:  M A Horwitz; F R Maxfield
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

8.  The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

9.  Characterization of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  20 in total

1.  IcmF and DotU are required for optimal effector translocation and trafficking of the Legionella pneumophila vacuole.

Authors:  Susan M VanRheenen; Guillaume Duménil; Ralph R Isberg
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 2.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy.

Authors:  Kerstin Pohl; Xue A Grimm; Silvia M Caceres; Katie R Poch; Noel Rysavy; Milene Saavedra; Jerry A Nick; Kenneth C Malcolm
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

4.  Phosphoinositide3-kinase regulates actin polymerization during delayed phagocytosis of Helicobacter pylori.

Authors:  Lee-Ann H Allen; J Aaron Allgood; Xuemei Han; Lara M Wittine
Journal:  J Leukoc Biol       Date:  2005-04-04       Impact factor: 4.962

5.  Akt-mediated proinflammatory response of mononuclear phagocytes infected with Burkholderia cenocepacia occurs by a novel GSK3β-dependent, IκB kinase-independent mechanism.

Authors:  Thomas J Cremer; Prexy Shah; Estelle Cormet-Boyaka; Miguel A Valvano; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

6.  A Legionella pneumophila-translocated substrate that is required for growth within macrophages and protection from host cell death.

Authors:  Rita K Laguna; Elizabeth A Creasey; Zhiru Li; Nicole Valtz; Ralph R Isberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-21       Impact factor: 11.205

7.  The purified and recombinant Legionella pneumophila chaperonin alters mitochondrial trafficking and microfilament organization.

Authors:  Audrey Chong; Celia A Lima; David S Allan; Gheyath K Nasrallah; Rafael A Garduño
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

8.  PI 3-kinase independent role for AKT in F-actin regulation during outer segment phagocytosis by RPE cells.

Authors:  Ayelen Bulloj; Wei Duan; Silvia C Finnemann
Journal:  Exp Eye Res       Date:  2013-05-10       Impact factor: 3.467

9.  Chemical genetics reveals bacterial and host cell functions critical for type IV effector translocation by Legionella pneumophila.

Authors:  Xavier Charpentier; Joëlle E Gabay; Moraima Reyes; Jing W Zhu; Arthur Weiss; Howard A Shuman
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

Review 10.  Host signal transduction and protein kinases implicated in Legionella infection.

Authors:  Andrew D Hempstead; Ralph R Isberg
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.